04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
The Setting Every Community Up For Retirement Enhancement (“SECURE”) Act, which was enacted into l...
Read More >
Under generally accepted Title VII principles, an employer can be held liable when a co-worker haras...
Read More >
Construction partner Laurie Stanziale and Litigation partner and host Rich Schoenstein discuss Const...
Read More >
As reported in our November 7, 2018 SW Benefits Blog Zombie Benefits – Are Health Reimbursement Arr...
Read More >
In today’s edition of Daily Compliance News: 1. Once a cheat, always a cheat? (NYT) 2. EY getting ...
Read More >
Proposed revisions to current financial statement disclosure requirements for business acquisitions ...
Read More >